UAE
Ethiopia
LIVERFASt™
Blood-based liver evaluation test that uses 10 biomarkers and advanced technology to determine the condition the liver
Blood-based liver evaluation test that uses 10 biomarkers and advanced technology to determine the condition the liver
LIVERFASt™ provides a score from 0.00 to 1.00 and its estimated grade or stage, similar to the histopathological scoring of the liver (based on the liver biopsy classification).
Simple and easy-to-do
LIVERFASt™
LIVERFASt™ takes inputs from 10 biomarkers and patient anthropometrics to generate a score from 0.00 to 1.00 that corresponds to the histopathological staging of a liver biopsy.
| STAGE | INTERPRETATION |
| FO | No fibrosis |
| F1 | Mild fibrosis |
| F2 | Advanced fibrosis |
| F1 | Significant fibrosis |
| F4 | Severe fibrosis/cirrhosis |
| STAGE | INTERPRETATION |
| FO | No activity |
| F1 | Mild activity |
| F2 | Moderate activity |
| F1 | Marked activity |
| F4 | Severe activity |
| STAGE | INTERPRETATION |
| sO | No steatosis (<5%) |
| s1 | Mild steatosis(5-33%) |
| s2 |
Moderate steatosis(34-66%) |
| s3 | Marked steatosis (≥ 67%) |
LIVERFASt, the best screening tool that also stages liver fibrosis, steatosis & inflammatory activity
LIVERFASt™ seamlessly integrates into any clinical or healthcare setting, without disrupting clinical processes or practice
